Michelle Snyder (McIntire ’92)
Senior Director/Team Lead, U.S. Oncology Portfolio Acceleration/Commercial Effectiveness, Pfizer
Michelle Snyder has been with Pfizer for over 19 years and currently is a member of the U.S. Oncology Leadership Team within the Biopharma Business. She is responsible for insight generation and innovation across Pfizer's Oncology portfolio, which covers cancers including breast, cancer, lung, and prostate, among others. Her team's main focus is on leveraging data and analytics to identify insights that increase competitive advantage, designing and implementing innovative solutions, and scaling these across the portfolio to increase growth opportunities. Furthermore, Snyder has held several other positions within Pfizer, including Director of Digital Analytics and Innovation, Director of Market Analytics for Oncology (Breast, Hematology), and Director of Market Analytics for Pfizer Innovative Health (Respiratory and Neuroscience).
Prior to joining Pfizer, Snyder was a Consultant with the Boston Consulting Group in Atlanta, GA. In addition, she worked at PricewaterhouseCoopers (now IBM), where she planned and implemented large technology system solutions for Fortune 500 clients in the insurance, entertainment, and telecommunications industries.
Snyder holds a B.S. in Commerce from the University of Virginia (McIntire School of Commerce) and an MBA from Duke University (Fuqua School of Business).